MMCM
ARKG icon

Murphy & Mullick Capital Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Murphy & Mullick Capital Management’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$528 Hold
20
– – ﹤0.01% 655
2025
Q4 		$579 Hold
20
– – ﹤0.01% 661
2025
Q3 		$596 Hold
20
– – ﹤0.01% 641
2025
Q2 		$487 Hold
20
– – ﹤0.01% 641
2025
Q1 		$415 Hold
20
– – ﹤0.01% 636
2024
Q4 		$471 Buy
+20
New +$492 ﹤0.01% 625

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Murphy & Mullick Capital Management's ARKG Position: Q1 2026 in Review

Murphy & Mullick Capital Management held its ARK Genomic Revolution ETF (ARKG) position steady in Q1 2026 at 20 shares worth $528. The position accounts for ﹤0.01% of the portfolio, ranked #655.

Murphy & Mullick Capital Management first reported a position in ARKG in Q4 2024 and has held it in 6 quarters since. The position peaked at $596 in Q3 2025. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.

  • Murphy & Mullick Capital Management held 20 shares of ARK Genomic Revolution ETF worth $528 as of Q1 2026.
  • Murphy & Mullick Capital Management left its ARK Genomic Revolution ETF share count unchanged in Q1 2026.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Murphy & Mullick Capital Management's portfolio in Q1 2026, its #655 holding.
  • Murphy & Mullick Capital Management first reported a position in ARK Genomic Revolution ETF in Q4 2024 and has held it in 6 quarters since.
  • Murphy & Mullick Capital Management's ARK Genomic Revolution ETF position peaked at $596 in Q3 2025.
  • 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.

Based on Murphy & Mullick Capital Management's 13F filing for Q1 2026, filed 17 Apr 2026.